Open AccessBrUOG 345: Fractionated Gemtuzumab Ozogamicin Followed By Non-Engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia
Author(s) -
Adam Zayac,
Pamela Egan,
Thomas Ollila,
Adam J. Olszewski,
Peter Barth,
Matthew I. Quesenberry,
James N. Butera,
Loren D. Fast,
Rabin Niroula,
Peter J. Quesenberry,
John L. Reagan
Publication year - 2019
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood-2019-123789
Subject(s) - medicine , gemtuzumab ozogamicin , donor lymphocyte infusion , bone marrow , myeloid leukemia , minimal residual disease , transplantation , leukemia , immunology , gastroenterology , stem cell , graft versus host disease , cd34 , cd33 , genetics , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom